Medicare Enrolled

Dr. Craig Kunins, M.D.

Child & Adolescent Psychiatry Physician · Gulfport, FL
2840 SEABREEZE DR S, Gulfport, FL 33707
7276924505
Registered in NPPES since 2006
NPI: 1821158742 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kunins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kunins? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kunins

Dr. Craig Kunins is a child & adolescent psychiatry physician in Gulfport, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Kunins received a total of $300,194 from 28 pharmaceutical and/or device companies across 627 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kunins is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $300,194 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$300,194
Total received (2018-2024)
Avg $42,885/year across 7 years
Top 0% in FL for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
627
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,421
2023
$37,716
2022
$44,594
2021
$57,576
2020
$25,796
2019
$96,359
2018
$35,733

Payments by company (2024)

IRONSHORE PHARMACEUTICALS INC.
$1,845
Axsome Therapeutics, Inc.
$234
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$125
Alkermes, Inc.
$110
Supernus Pharmaceuticals, Inc.
$107
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
Ironshore Pharmaceuticals Inc.
$138,381
Corium, LLC
$53,395
Supernus Pharmaceuticals, Inc.
$40,040
Shire North American Group Inc
$25,499
Takeda Pharmaceuticals U.S.A., Inc.
$18,354
Neos Therapeutics, LP
$11,140
Adlon Therapeutics L.P.
$6,750
IRONSHORE PHARMACEUTICALS INC.
$1,845
Teva Pharmaceuticals USA, Inc.
$702
ITI, Inc.
$434
Otsuka America Pharmaceutical, Inc.
$412
Allergan Inc.
$388
Sunovion Pharmaceuticals Inc.
$368
Axsome Therapeutics, Inc.
$352
ABBVIE INC.
$340
Purdue Pharma L.P.
$254
Alkermes, Inc.
$217
AbbVie Inc.
$192
JAZZ PHARMACEUTICALS INC.
$188
Janssen Pharmaceuticals, Inc
$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$125
IDORSIA PHARMACEUTICALS US INC
$124
Eisai Inc.
$124
LivaNova USA, Inc.
$121
Corium, Inc.
$114
Avanir Pharmaceuticals, Inc.
$88
Otsuka Pharmaceutical Development & Commercialization, Inc.
$45
Rhodes Pharmaceuticals L.P.
$32
Top 3 companies account for 77.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Austedo XR · Auvelity · Azstarys · CAPLYTA · Dayvigo · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · MYDAYIS · NUEDEXTA · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · SUNOSI · VNS - Symmetry · VRAYLAR · VYVANSE · Vyvanse
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a child & adolescent psychiatry physician in Gulfport?
Compare child & adolescent psychiatry physicians in the Gulfport area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians in nearby ZIP areas
25
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA PASADENA HOSPITAL A PART OF HCA FLORID
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kunins is a child & adolescent psychiatry physician, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Kunins receive payments from pharmaceutical companies?
Yes. Dr. Kunins received a total of $300,194 from 28 companies across 627 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kunins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Child & Adolescent Psychiatry Physicians in Gulfport
Browse child & adolescent psychiatry physicians in Gulfport ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in FL
Child & adolescent psychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in FL
Which FL child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Ironshore Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ironshore Pharmaceuticals Inc.
By company
Corium, LLC Payments to Doctors
See all physicians who received payments from Corium, LLC.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →